# The Effect of a Synbiotic on Intestinal Barrier Function and Microbiota Modulation in Middle-aged to Elderly Individuals With Excessive Body Weight

> **NCT07453823** · NA · RECRUITING · sponsor: **Chr Hansen - part of Novonesis** · enrollment: 90 (estimated)

## Conditions studied

- Gastrointestinal Microbiome (Focus)
- Gastrointestinal Symptoms

## Interventions

- **DIETARY_SUPPLEMENT:** Synbiotic
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT07453823
- **Lead sponsor:** Chr Hansen - part of Novonesis
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-18
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07453823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07453823, "The Effect of a Synbiotic on Intestinal Barrier Function and Microbiota Modulation in Middle-aged to Elderly Individuals With Excessive Body Weight". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT07453823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*